Cite
Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma.
MLA
Waninger, Jessica J., et al. “Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma.” Cancers, vol. 14, no. 23, Dec. 2022, p. 5789. EBSCOhost, https://doi.org/10.3390/cancers14235789.
APA
Waninger, J. J., Fecher, L. A., Lao, C., Yentz, S., Green, M. D., & Demirci, H. (2022). Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma. Cancers, 14(23), 5789. https://doi.org/10.3390/cancers14235789
Chicago
Waninger, Jessica J., Leslie A. Fecher, Christopher Lao, Sarah Yentz, Michael D. Green, and Hakan Demirci. 2022. “Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma.” Cancers 14 (23): 5789. doi:10.3390/cancers14235789.